Jefferies analyst Brian Tanquilut raised the price target on Biostage (OTC: BSTG) to $25.00 (from $22.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE